SI1561460T1 - Nanodelci za aplikacijo uäśinkovin, postopek za pripravo teh delcev in sestavek, ki jih vsebuje - Google Patents

Nanodelci za aplikacijo uäśinkovin, postopek za pripravo teh delcev in sestavek, ki jih vsebuje

Info

Publication number
SI1561460T1
SI1561460T1 SI200330701T SI200330701T SI1561460T1 SI 1561460 T1 SI1561460 T1 SI 1561460T1 SI 200330701 T SI200330701 T SI 200330701T SI 200330701 T SI200330701 T SI 200330701T SI 1561460 T1 SI1561460 T1 SI 1561460T1
Authority
SI
Slovenia
Prior art keywords
nanoparticles
active ingredients
administration
producing
containing same
Prior art date
Application number
SI200330701T
Other languages
English (en)
Inventor
Fernandez Maria Jose Alonso
Lopez Carmen Remunan
Vilan Margarita Maria Cuna
Sande Maria Alonso
Jato Jos Luis Vila
Original Assignee
Advanced In Vitro Cell Technologies S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced In Vitro Cell Technologies S L filed Critical Advanced In Vitro Cell Technologies S L
Publication of SI1561460T1 publication Critical patent/SI1561460T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
SI200330701T 2002-07-19 2003-07-16 Nanodelci za aplikacijo uäśinkovin, postopek za pripravo teh delcev in sestavek, ki jih vsebuje SI1561460T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200201694A ES2221530B1 (es) 2002-07-19 2002-07-19 Nanoparticulas para la administracion de ingredientes activos,procedimiento para la elaboracion de dichas particulas y composicion que las contienen.
EP03765124A EP1561460B1 (en) 2002-07-19 2003-07-16 Nanoparticles for the administration of active ingredients, method of producing said particles and composition containing same
PCT/ES2003/000372 WO2004009060A1 (es) 2002-07-19 2003-07-16 Nanopartículas para la administración de ingredientes activos, procedimiento para la elaboración de dichas partículas y composición que las contienen.

Publications (1)

Publication Number Publication Date
SI1561460T1 true SI1561460T1 (sl) 2007-06-30

Family

ID=30470576

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330701T SI1561460T1 (sl) 2002-07-19 2003-07-16 Nanodelci za aplikacijo uäśinkovin, postopek za pripravo teh delcev in sestavek, ki jih vsebuje

Country Status (11)

Country Link
US (1) US20060134785A1 (sl)
EP (1) EP1561460B1 (sl)
AT (1) ATE348602T1 (sl)
CA (1) CA2492995A1 (sl)
CY (1) CY1106361T1 (sl)
DE (1) DE60310605T2 (sl)
DK (1) DK1561460T3 (sl)
ES (2) ES2221530B1 (sl)
PT (1) PT1561460E (sl)
SI (1) SI1561460T1 (sl)
WO (1) WO2004009060A1 (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
WO2007036946A1 (en) * 2005-09-28 2007-04-05 Padma Venkitachalam Devarajan Compositions for enhanced absorption of biologically active agents
EP1774971A1 (en) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Chitosan and heparin nanoparticles
WO2007149868A2 (en) * 2006-06-20 2007-12-27 The Regents Of The University Of California Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
US9173852B2 (en) * 2008-04-08 2015-11-03 Tian Si Polymer Materials Technology Development Co. Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof
JP5804453B2 (ja) * 2009-05-14 2015-11-04 国立大学法人 東京大学 結晶性ポリオール微粒子及びその調製方法
BR112012000472A2 (pt) * 2009-07-09 2016-02-23 Polymers Crc Ltd sistema de liberação de gel-depósito de biopolímero híbrido
DE102009048553A1 (de) 2009-09-29 2011-03-31 Carl Zeiss Smt Gmbh Katadioptrisches Projektionsobjektiv mit Umlenkspiegeln und Projektionsbelichtungsverfahren
US8802076B2 (en) 2010-10-04 2014-08-12 Duke University Compositions and methods for modulating an immune response
JP5903250B2 (ja) * 2011-11-16 2016-04-13 清水化学株式会社 徐放性組成物
KR101372834B1 (ko) * 2011-12-12 2014-03-14 전북대학교산학협력단 하이드로겔 버블 및 이의 제조방법
US9114091B2 (en) * 2013-07-05 2015-08-25 Shimizu Chemical Corporation Sustained release solid dosage preparations
CN107970228A (zh) * 2017-11-02 2018-05-01 天津大学 一种以壳聚糖-tpp-kgm为复合壁材的纳米微囊的制备方法
CN111420067B (zh) * 2020-03-09 2021-08-27 西南交通大学 一种复合微球纳米载体及其制备方法和应用
WO2021209493A2 (en) * 2020-04-15 2021-10-21 Solyplus Gmbh Means and methods of preventing and treating infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688422A1 (fr) * 1992-03-11 1993-09-17 Coletica Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
ES2114502B1 (es) * 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.

Also Published As

Publication number Publication date
DE60310605D1 (de) 2007-02-01
CA2492995A1 (en) 2004-01-29
PT1561460E (pt) 2007-03-30
CY1106361T1 (el) 2011-10-12
DK1561460T3 (da) 2007-04-30
ATE348602T1 (de) 2007-01-15
US20060134785A1 (en) 2006-06-22
WO2004009060A1 (es) 2004-01-29
ES2221530A1 (es) 2004-12-16
DE60310605T2 (de) 2007-09-27
EP1561460B1 (en) 2006-12-20
EP1561460A1 (en) 2005-08-10
ES2221530B1 (es) 2006-02-16
ES2279172T3 (es) 2007-08-16

Similar Documents

Publication Publication Date Title
SI1561460T1 (sl) Nanodelci za aplikacijo uäśinkovin, postopek za pripravo teh delcev in sestavek, ki jih vsebuje
AU3731699A (en) Orally disintegrable tablets
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
MY145790A (en) Composition
ATE350013T1 (de) Nanopartikelzusammensetzungen enthaltend insulin
BG105459A (en) Pharmaceutical moxifloxacin preparation
MXPA02001254A (es) Formulacion de moxifloxacino con sal-comun.
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
WO2004067027A3 (en) Osteogenic composition
KR101866926B1 (ko) 구강유용물질을 포함하는 구강용 캡슐 및 그 제조방법
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
NZ510360A (en) Fish gelatinous composition for use as an ingredient in tablets
WO2007037790A3 (en) Modified release famciclovir compositions
CA2429793A1 (en) Interferon therapeutic effect enhancer
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
MXPA04002517A (es) Composiciones para el control del apetito y metodos relacionados.
WO2002053099A3 (en) Methods and compositions for treating periodontal disease
MXPA04002099A (es) Composiciones medicinales para neuropatia diabetica.
Yahya et al. Nanoparticles as Endodontic Irrigation: An Update Overview
AU2001237768A1 (en) Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
US20150147368A1 (en) Oral mouth rinse